(Q46116839)

English

Open-label support for duloxetine for the treatment of panic disorder

scientific article published in January 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Open-label support for duloxetine for the treatment of panic disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Elizabeth A. Hoge

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19228176

Rebecca K. Sripada

object named as

Rebecca E Kaufman

2

0 references

author name string

Naomi M Simon

1

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

John J Worthington

4

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Nannette N Herlands

5

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Maryann E Owens

6

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Mark H Pollack

7

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

publication date

1 January 2009

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

CNS Neuroscience & Therapeutics

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

15

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

1

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

19-23

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Multicenter collaborative panic disorder severity scale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00076.X

21 January 2018

The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacotherapy of panic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice. Panic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive behavior therapy for treatment-refractory panic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228176

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1755-5949.2008.00076.X

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6494018

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46116839&oldid=2093387146"